Similarly, loss of H3K9 methylation at the BCAT1 gene promoter coincides with increased BCAT1 expression in tyrosine kinase inhibitor (TKI)-resistant epidermal growth factor receptor (EGFR)-mutant lung cancer cells. Here, EGFR is linked to lung cancer.